|Articles|February 1, 2019
- Pharmaceutical Executive-02-01-2019
- Volume 39
- Issue 2
Pharmaceutical Executive, February 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Q&A: Regulatory Reform in Chinaover 7 years ago
China: A Change in Attitudeover 7 years ago
New Roads to Chinaover 7 years ago
Closing the Pharma and Digital Health Divideover 7 years ago
A Leading Man’s Next Actover 7 years ago
Two Steps Forwardover 7 years ago
Let the Drug Pricing Games Beginover 7 years ago
Mixed Outlook for China Life Sciencesover 7 years ago
CFIUS Reform’s Impact on Biopharmaover 7 years ago
Op-Ed: Opening the Golden DoorAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
2
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5